BRANMOOR
THURSDAY · 14 MAY 2026

FDA Recall D-0488-2023

Global Pharma Healthcare Private Limited · Chennai, N/A

Class I — life-threatening Ongoing 1175 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death. Distribution is nationwide and the recall remains in progress.

Product

Delsam Pharma's Artificial Eye Ointment (Mineral Oil 15%, White Petrolatum 83%), 3.5 grams (1/8 oz.) tube, Distributed By: Delsam Pharma Lic, Bronx, Newyork 10469, NDC 72570 122 35, UPC 3 72570 12235 3.

Lot / code: Batch # H29, Exp. Date 11/30/2023

Quantity: 50,000 tubes

Reason for recall

Non-Sterility: FDA analysis found unopened tubes to be contaminated with bacteria.

Recall record

Recall number
D-0488-2023
Classification
Class I
Status
Ongoing
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Press Release
Distribution
Product was imported by one distributor, Delsam Pharma, LLC, who further distributed the product via internet sales Nationwide in the USA.
Recall initiated
2023-02-24
Classified by FDA Center
2023-03-30
FDA published
2023-03-29
Recalling firm
Global Pharma Healthcare Private Limited
Firm location
Chennai, N/A, India

Operational response

A Class I recall indicates a strong likelihood of serious adverse health consequence or death. Pull affected lots from active dispensing immediately. Segregate inventory in a marked, locked location pending destruction or return. If product has already been dispensed, identify affected patients and contact them by your standard recall-notification protocol.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls